DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
10,300
Employees10,300
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
10,300
Employees10,300

DXCM Key Statistics

Market cap
27.29B
Market cap27.29B
Price-Earnings ratio
38.94
Price-Earnings ratio38.94
Dividend yield
Dividend yield
Average volume
5.10M
Average volume5.10M
High today
$70.77
High today$70.77
Low today
$68.68
Low today$68.68
Open price
$70.57
Open price$70.57
Volume
3.66M
Volume3.66M
52 Week high
$93.25
52 Week high$93.25
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

As of today, DexCom(DXCM) shares are valued at $69.87. The company's market cap stands at 27.29B, with a P/E ratio of 38.94.

As of 2026-02-07, DexCom(DXCM) stock has fluctuated between $68.68 and $70.77. The current price stands at $69.87, placing the stock +1.7% above today's low and -1.3% off the high.

The DexCom(DXCM)'s current trading volume is 3.66M, compared to an average daily volume of 5.1M.

In the last year, DexCom(DXCM) shares hit a 52-week high of $93.25 and a 52-week low of $54.11.

In the last year, DexCom(DXCM) shares hit a 52-week high of $93.25 and a 52-week low of $54.11.

DXCM News

Simply Wall St 6h
Dexcom Stelo AI Update Links Glucose Data To Everyday Metabolic Health

Dexcom (NasdaqGS:DXCM) is rolling out advanced AI-enabled features to its Stelo glucose monitoring platform. The update introduces detailed nutrition logging w...

Dexcom Stelo AI Update Links Glucose Data To Everyday Metabolic Health
Nasdaq 21h
August 21st Options Now Available For DexCom

Investors in DexCom Inc (Symbol: DXCM) saw new options begin trading today, for the August 21st expiration. One of the key data points that goes into the price...

August 21st Options Now Available For DexCom
Simply Wall St 5d
What DexCom's Strong Q4 Beat and Margin Guidance Means For Shareholders

In late January 2026, DexCom reported preliminary fourth-quarter results that surpassed consensus expectations, with year-over-year revenue growth across both U...

What DexCom's Strong Q4 Beat and Margin Guidance Means For Shareholders

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
15.2%
Sell
3%

More DXCM News

Simply Wall St 7d
DexCom Faces Split Analyst Views As Competition Pressures Core CGM Markets

Barclays downgraded DexCom on concerns about rising competition in its core insulin intensive market segments. Other major analysts maintained more positive ou...

DexCom Faces Split Analyst Views As Competition Pressures Core CGM Markets

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.